Friday, 20 Oct 2017

Drug Safety

Datesort ascending Type Title Save
14 Oct 2017 Social RheumNow Wk in Review is Up! watch video or listen to the podcast. Please rate us at iTunes https://t.co/Wao7JS1a2I https://t.co/phhYQzRX4j
13 Oct 2017 Social RT @RonanTKavanagh: Autoimmune thyroid disease as a possible S/E of Anti TNF agents. Didn’t know that. Til today. https://t.co/y9VO3HkedA #…
13 Oct 2017 Social Anfibrotic effx of antiviral Nelfinavir shown to decr TGF-β1-mediated pulm fibrosis & myofibroblast differentiation https://t.co/dSMmMuzYLh
10 Oct 2017 Social 31465 on ULT, allopurinol assoc w/ 39% lower risk renal dz (HR 0.61 vs febuxostat). Higher doses = more protection https://t.co/EsJuyBt3Cy
10 Oct 2017 Social 21 w/ Henoch Schonlein Purpura Rx w/ RTX: 20/21 achieved remission; w/ improved Proteinuria, BVAS, CRP; 35% relapsed https://t.co/NR6c9E1d0s
09 Oct 2017 Social Jan 1st CIGNA will stop covering Oxycontin - is this improved safety or another way to max $$$ &reduce company risk? https://t.co/2TLnnsK80X
09 Oct 2017 Social HCQ decreases CV events, DM 41% & benefits metabolic profile in RA- HCQ useful add on w/ other DMARDs @DrPetryna https://t.co/wnLEqcDkuN
09 Oct 2017 Social Annual costs assoc w/ adverse drug events in US rose from $76.6 billion 1995 to >$177.4 bill 2000; hosp 70% of total https://t.co/WPgW0AlyKK
08 Oct 2017 Social RheumNOw Wk in Review is Up! Tof lymphoma risk, early Dx of RA, Preg & biologics, 2016 top 5 Rheumatology drugs. https://t.co/UypuxfiFyu
08 Oct 2017 Social RT @DrPetryna: Report fromHCQ decreases CV events&benefits metabolic profile in RA- HCQ useful add on w/other DMARDs @RheumNow https://t.…
06 Oct 2017 Social 2016 US Top selling drugs: Humira $13.6 billion, Enbrel $7.4 billion, Remicade $5.3 billion, Lyrica $4.4B,RTX $3.9B https://t.co/FZM2Vow44n
05 Oct 2017 Social RheumNow has the Rules for Stopping Biologics or DMARDs in the setting of infection, esp nonserious infections. https://t.co/3a9lMCLcR1
05 Oct 2017 Social Tramadol dosing: max is 400 mg/d. For those >75 yrs, the max is 300 mg/f; those w/ CKD (<30 mL/min) 200 mg/d https://t.co/3mbn9xiHVi
03 Oct 2017 Social `07 JIA pts followed for 3 yrs on Biologics- 25% (35) had Serious/Opportunistic infx. range 10.6-14.8/100py https://t.co/8kad5PmLKR
03 Oct 2017 Social In 19 RCTs, 6194 RA pts received tofacitinib for 19406 pt-Yrs & 19 developed lymphoma (SIR 2.62) or 1:1000 PY risk https://t.co/UuWEQmGEGB
02 Oct 2017 Social Systematic review shows Colchicine during pregnancy doesn't increase malformations or miscarriage in FMF women. https://t.co/FPaaweU78H
02 Oct 2017 Social RA RCT Inclusion of FM or Depression pts or pts on SSRI had 10% less ACR20 & 1/2 LDAS responses, more W/D & AE https://t.co/TaXhrLsxPU
01 Oct 2017 Social You can Search the FDA FAERS (MedWatch) for Drug specific Adverse events - Cool! https://t.co/FgMyj2OfZx
01 Oct 2017 Social RheumNow Wk in Review is up! Podcast https://t.co/wn1XB7TY43 or Watch it!! https://t.co/h6fppDdYcH
29 Sep 2017 Social RheumNow Wk in Review is up! Podcast https://t.co/j3K7fjbXOG or Watch it!! https://t.co/ymFBPEHuY4